Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial
Circulation · 03.12.2024 · 150 (23) · 1826-1836
DOI: 10.1161/circulationaha.124.071208 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 03.12.2024. Verfasst von Andrew P DeFilippis und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (A.P.D.). Hauptthemen laut MEDLINE: Myocardial Infarction, Blood Transfusion, Anemia. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute, Canadian Government | Canadian Institutes of Health Research.
Abstract (Originalsprache)
BACKGROUND: The MINT trial (Myocardial Ischemia and Transfusion) raised concern for harm from a restrictive versus liberal transfusion strategy in patients with acute myocardial infarction (MI) and anemia. Type 1 and type 2 MI are distinct pathophysiologic entities that may respond differently to blood transfusion. This analysis sought to determine whether the effects of transfusion varied among patients with a type 1 or a type 2 MI and anemia. The authors hypothesized that the liberal transfusion strategy would be of greater benefit in type 2 than in type 1 MI. METHODS: The authors compared rates of death or MI at 30 days in patients with type 1 (n=1460) and type 2 (n=1955) MI and anemia who were randomly allocated to a restrictive (threshold, 7–8 g/dL) or a liberal (threshold, 10 g/dL) transfusion strategy. RESULTS: The primary outcome of death or MI was observed in 16% of type 1 MI and 15.4% of type 2 MI patients. The rate of death or MI was higher in patients with type 1 MI randomized to a restrictive (18.2%) versus liberal (13.8%) transfusion strategy (relative risk [RR], 1.32 [95% CI, 1.04–1.67]) with no difference observed between the restrictive (15.8%) and liberal (15.1%) transfusion strategies in patients with type 2 MI (RR, 1.05 [95% CI, 0.85–1.29]). The test for a differential effect of transfusion strategy by MI type was not statistically significant ( P interaction = 0.16). CONCLUSIONS: The concern for harm with a restrictive transfusion strategy in patients with acute MI and anemia raised in the MINT primary outcome manuscript may be more apparent in patients with type 1 than type 2 MI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02981407.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (A.P.D.).
- Lifespan Cardiovascular Institute and Department of Medicine, Division of Cardiology, Alpert Medical School of Warren Alpert Medical School. Brown University, Providence, RI (J.D.A.).
- University of Pittsburgh School of Public Health, PA (B.M.H., M.H.B., M.M.B.).
- St Louis University School of Medicine, MO (B.R.C.).
- Green Lane Coordinating Center, Auckland, New Zealand (H.D.W., C.A.).
- Department of Medicine, Baystate Medical Center, Springfield, MA (A.M.G.).
ORCID-Profile: Andrew P DeFilippis, J Dawn Abbott, Brandon M Herbert, Marnie H Bertolet, Bernard R Chaitman, Harvey D White, Andrew M Goldsweig, Tamar S Polonsky, Rajesh Gupta, Caroline Alsweiler, Johanne Silvain, Pedro G M de Barros E Silva, Graham S Hillis, Sunil V Rao, Renato D Lopes, Paul C Hébert, John H Alexander, Maria M Brooks, Jeffrey L Carson, Shaun G Goodman
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute
- Canadian Government | Canadian Institutes of Health Research
- French National Research Agency
Zitieren
APA
DeFilippis, A. P., Abbott, J. D., Herbert, B. M., Bertolet, M. H., Chaitman, B. R., White, H. D., Goldsweig, A. M., Polonsky, T. S., Gupta, R., Alsweiler, C., Silvain, J., de Barros E Silva, P. G. M., Hillis, G. S., Daneault, B., Tessalee, M., Menegus, M. A., Rao, S. V., Lopes, R. D., Hébert, P. C., …, & MINT Investigators (2024). Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation, 150(23), 1826-1836. https://doi.org/10.1161/circulationaha.124.071208
Vancouver
DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD, et al. Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial. Circulation. 2024;150(23):1826-1836. doi:10.1161/circulationaha.124.071208
BibTeX
@article{DeFilippis2024,
author = {DeFilippis, Andrew P and Abbott, J Dawn and Herbert, Brandon M and Bertolet, Marnie H and Chaitman, Bernard R and White, Harvey D and Goldsweig, Andrew M and Polonsky, Tamar S and Gupta, Rajesh and Alsweiler, Caroline and Silvain, Johanne and de Barros E Silva, Pedro G M and Hillis, Graham S and Daneault, Benoit and Tessalee, Meechai and Menegus, Mark A and Rao, Sunil V and Lopes, Renato D and Hébert, Paul C and Alexander, John H and Brooks, Maria M and Carson, Jeffrey L and Goodman, Shaun G and MINT Investigators, MINT Investigators},
title = {Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial},
journal = {Circulation},
year = {2024},
volume = {150},
number = {23},
pages = {1826--1836},
doi = {10.1161/circulationaha.124.071208}
}
EUVIMED